SCHEMBL7284694

SCHEMBL7284694

COC(OC)[C@@H]1CCCN1C(=O)CCC(=O)N(C)Cc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PREP P48147 2/20 0.53
NPC1 O15118 3/20 0.51
RAB9A P51151 2/20 0.51
CPT2 P23786 1/20 0.45
CPT1A P50416 1/20 0.45
KMT2A Q03164 2/20 0.45
BCHE P06276 1/20 0.43
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
KCNH2 Q12809 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41
LMNA P02545 1/20 0.41
ACE P12821 1/20 0.41
MEN1 O00255 1/20 0.41
POLB P06746 1/20 0.41
PKM P14618 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7293959 0.86 NPC1 (0.52) NPC1RAB9ACPT2CPT1AKMT2A
SCHEMBL7300169 0.86 NPC1 (0.52) NPC1RAB9ACPT2CPT1AKMT2A
Water SCHEMBL7291220 0.85 NPC1 (0.51) NPC1RAB9ACPT2CPT1AKMT2A
SCHEMBL7291828 0.85 NPC1 (0.51) NPC1RAB9ACPT2CPT1AKMT2A
SCHEMBL7281110 0.85 NPC1 (0.51) NPC1RAB9ACPT2CPT1AKMT2A
Water SCHEMBL7291216 0.85 NPC1 (0.51) NPC1RAB9ACPT2CPT1AKMT2A
SCHEMBL7291820 0.85 NPC1 (0.51) NPC1RAB9ACPT2CPT1AKMT2A
SCHEMBL7284726 0.85 L3MBTL1 (0.49) NPC1RAB9ACPT2CPT1AKMT2A
SCHEMBL7284724 0.85 L3MBTL1 (0.49) NPC1RAB9ACPT2CPT1AKMT2A
SCHEMBL7282114 0.84 NPC1 (0.50) NPC1RAB9ACPT2CPT1AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0537802-B1 N-acylpyrrolidines, process for their preparation and their use for prevention and/or treatment of amnesia ONO PHARMACEUTICAL CO (JP) 1999-08-25 EP claimed
US-5545657-A 1-ALKYLOYLPYRROLIDIN-2-YLOXOALKANOIC ACIDS AND DERIVATIVES; ANTIAMNESIA AGENTS; INHIBITORS OF PROLYL ENDOPEPTIDASE; SUPPRESSION OF NEUROTRANSMITTER METABOLISM ONO PHARMACEUTICAL CO., LTD. (JP) 1996-08-13 US claimed
EP-0537802-A2 N-acylpyrrolidines and N-acylthiazolidines, process for their preparation and their use for prevention and/or treatment of amnesia ONO PHARMACEUTICAL CO., LTD. (JP) 1993-04-21 EP claimed
EP-0345428-A1 Anti-amnesic pyrrolidine derivatives ONO PHARMACEUTICAL CO., LTD. (JP) 1989-12-13 EP claimed
EP-0965585-A1 Anti-amnesic thiazolidine derivatives ONO PHARMACEUTICAL CO., LTD. (JP) 1999-12-22 EP disclosed
EP-0537802-B1 N-acylpyrrolidines, process for their preparation and their use for prevention and/or treatment of amnesia ONO PHARMACEUTICAL CO (JP) 1999-08-25 EP disclosed
US-5411974-A Thiazoline derivatives, treatment of amnesia ONO PHARMACEUTICAL CO., LTD. (JP) 1995-05-02 US disclosed
US-5401760-A Thiazoline derivative for treating amnesia ONO PHARMACEUTICAL CO., LTD. (JP) 1995-03-28 US disclosed
US-5212191-A Thiazoline derivatives for treatment of amnesia ONO PHARMACEUTICAL CO., LTD. (JP) 1993-05-18 US disclosed
EP-0537802-A2 N-acylpyrrolidines and N-acylthiazolidines, process for their preparation and their use for prevention and/or treatment of amnesia ONO PHARMACEUTICAL CO., LTD. (JP) 1993-04-21 EP disclosed
US-5053414-A Thiazolidine derivatives, enzyme inhibitors; amnesia ONO PHARMACEUTICAL CO., LTD. (JP) 1991-10-01 US disclosed
EP-0345428-A1 Anti-amnesic pyrrolidine derivatives ONO PHARMACEUTICAL CO., LTD. (JP) 1989-12-13 EP disclosed